We are live on ! Find out more
ZDA

Zweig-DiMenna Associates Portfolio holdings

AUM $722M
1-Year Est. Return 97.69%
This Fund
S&P 500
This Quarter Est. Return
-8.15%
1 Year Est. Return
+97.69%
3 Year Est. Return
+317.96%
5 Year Est. Return
+499.45%
10 Year Est. Return
+3,067.75%
AUM
$2.31B
AUM Growth
+$497M
Cap. Flow
+$761M
Cap. Flow %
32.95%
Top 10 Hldgs %
30.83%
Holding
324
New
77
Increased
76
Reduced
52
Closed
107

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$90.9M
2
AGN
Allergan plc
AGN
+$50.4M
3
CELG
Celgene Corp
CELG
+$48.9M
4
VRTX icon
Vertex Pharmaceuticals
VRTX
+$40M
5
ALXN
Alexion Pharmaceuticals
ALXN
+$39.2M

Top Sells

Rank Stock Value
1
BHI
Baker Hughes
BHI
+$34.4M
2
BABA icon
Alibaba
BABA
+$25M
3
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
+$23.5M
4
BA icon
Boeing
BA
+$19.8M
5
AMAT icon
Applied Materials
AMAT
+$18.9M

Sector Composition

Rank Sector Weight
1 Healthcare 23.17%
2 Consumer Discretionary 12.92%
3 Communication Services 9.83%
4 Technology 8.92%
5 Consumer Staples 7.38%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SNPS icon
276
Synopsys
SNPS
$79.7B
– –
-5,100
Closed -$258K
SNX icon
277
TD Synnex
SNX
$20.2B
– –
-6,800
Closed -$249K
STX icon
278
Seagate
STX
$184B
– –
-9,200
Closed -$437K
SU icon
279
Suncor Energy
SU
$70.3B
– –
-8,700
Closed -$239K
SYK icon
280
Stryker
SYK
$130B
– –
-2,600
Closed -$248K
TEX icon
281
Terex
TEX
$7.74B
– –
-10,800
Closed -$251K
TGT icon
282
Target
TGT
$68B
– –
-4,000
Closed -$327K
TPR icon
283
Tapestry
TPR
$32.8B
– –
-6,900
Closed -$239K
TRU icon
284
TransUnion
TRU
$15.3B
– –
-100,000
Closed -$2.51M
TRV icon
285
Travelers Companies
TRV
$80.2B
– –
-5,000
Closed -$483K
TSLA icon
286
CALL
Tesla
TSLA
$1.3T
– –
-1,200,000
Closed -$21.5M
TT icon
287
Trane Technologies
TT
$106B
– –
-255,120
Closed -$17.2M
VTRS icon
288
Viatris
VTRS
$18.9B
– –
-5,250
Closed -$356K
WAT icon
289
Waters Corp
WAT
$39.9B
– –
-1,900
Closed -$244K
YUM icon
290
Yum! Brands
YUM
$41.1B
– –
-286,755
Closed -$18.6M
QVCGA
291
DELISTED
QVC Group Inc Series A
QVCGA
– –
-179
Closed -$241K
TARO
292
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
– –
-1,800
Closed -$259K
SPLK
293
DELISTED
Splunk Inc
SPLK
– –
-143,249
Closed -$9.97M
BBBY
294
DELISTED
Bed Bath & Beyond Inc
BBBY
– –
-3,500
Closed -$241K
MNDT
295
DELISTED
Mandiant, Inc. Common Stock
MNDT
– –
-84,200
Closed -$4.12M
CDK
296
DELISTED
CDK Global, Inc.
CDK
– –
-4,600
Closed -$248K
MXIM
297
DELISTED
Maxim Integrated Products
MXIM
– –
-7,300
Closed -$252K
QEP
298
DELISTED
QEP RESOURCES, INC.
QEP
– –
-13,400
Closed -$248K
NE
299
DELISTED
Noble Corporation
NE
– –
-15,500
Closed -$239K
LM
300
DELISTED
Legg Mason, Inc.
LM
– –
-4,400
Closed -$227K
9 10 11
12
13

Similar funds

FIS
FCPM III Services Naarden, Netherlands $722M AUM 73.61% 1-Year Est. Return
PPW
Pasadena Private Wealth Pasadena, California $723M AUM 18.72% 1-Year Est. Return
VCM
Vivaldi Capital Management Chicago, Illinois $723M AUM 30.89% 1-Year Est. Return
AGAM
Avalon Global Asset Management San Francisco, California $724M AUM 52.97% 1-Year Est. Return
TFHU
TLT Family Holdco ULC Toronto $724M AUM 24.23% 1-Year Est. Return
FAN
Financial Advisors Network Tustin, California $724M AUM 14.91% 1-Year Est. Return
F
FIFTHDELTA London, United Kingdom $725M AUM 11.7% 1-Year Est. Return
TC
Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return

Zweig-DiMenna Associates's Q3 2015 Portfolio in Review

As of Q3 2015, Zweig-DiMenna Associates held 324 positions worth $2.31B, up 27% from $1.81B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Zweig-DiMenna Associates deployed $761M of net new capital in Q3 2015, opening 77 new positions and adding to 76 existing holdings. Its largest new stake was Celgene Corp: 394,282 shares worth $42.6M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 11% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Baker Hughes, an estimated $34.4M trimmed.

  • Zweig-DiMenna Associates's largest Q3 2015 buy was Celgene Corp: 394,282 shares worth $42.6M.
  • Zweig-DiMenna Associates added most to Bristol-Myers Squibb in Q3 2015, an estimated $90.9M increase.
  • Zweig-DiMenna Associates's biggest Q3 2015 reduction was Baker Hughes, cutting an estimated $34.4M.
  • Zweig-DiMenna Associates fully exited Alibaba in Q3 2015, selling an estimated $25M.
  • Zweig-DiMenna Associates's ten largest holdings make up 31% of its $2.31B portfolio in Q3 2015.
  • Zweig-DiMenna Associates opened 77 new positions and closed 107 in Q3 2015.
  • Zweig-DiMenna Associates's portfolio value rose 27% quarter-over-quarter to $2.31B.

Based on Zweig-DiMenna Associates's 13F filing for Q3 2015, filed 9 Nov 2015.